Clinical Applications of 68 Ga-DOTATOC PET/CT in the Evaluation and Management of Meningiomas: A Mini Review

Meningiomas are the most common primary intracranial tumors, and accurate imaging plays a central role in their diagnosis, risk assessment, treatment planning, and follow-up. Although many meningiomas are slow-growing, their clinical behavior can vary widely, with some tumors showing aggressive growth, postoperative recurrence, or complex extension into the skull base, bone, orbit, or dural venous sinuses. MRI and CT remain the standard imaging modalities for anatomic assessment; however, both have important limitations. MRI may be unable to reliably distinguish a residual or recurrent tumor from postoperative scarring, fibrosis, or radiation-related changes, whereas CT may be limited in differentiating reactive hyperostosis from true osseous tumor infiltration. Molecular imaging with 68Ga-DOTATOC PET/CT has emerged as a valuable complementary technique because of its high affinity for somatostatin receptor subtype 2, which is strongly expressed in most meningiomas. By providing high lesion-to-background contrast, 68Ga-DOTATOC PET/CT may improve lesion conspicuity and provide complementary information about disease extent in selected cases. Available evidence is strongest for problem-solving applications involving equivocal lesions and delineation of skull base, osseous, or optic nerve sheath disease, as well as confirmation of somatostatin receptor expression when receptor-targeted therapy is being considered. Other proposed applications, including tumor grading, prognostication, surgical planning, radiotherapy target refinement, quantitative response assessment, and routine surveillance, remain emerging and require prospective validation. This mini review summarizes the current applications, technical considerations, and limitations of 68Ga-DOTATOC PET/CT in meningioma management.

Authors

Institutions

Publication Details

Journal
Journal of Nuclear Medicine Technology
Published
2026-11-17
DOI
https://doi.org/10.2967/jnmt.126.273148
Primary Topic
Meningioma and schwannoma management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Applications of 68 Ga-DOTATOC PET/CT in the Evaluation and Management of Meningiomas: A Mini Review

Rashid Al Sukaiti, Khulood Al Riyami, Shah P. Numani, Sharjeel Usmani et al.
1 links
Journal of Nuclear Medicine Technology
Meningioma and schwannoma management
article

Clinical Applications of 68 Ga-DOTATOC PET/CT in the Evaluation and Management of Meningiomas: A Mini Review

Rashid Al Sukaiti, Khulood Al Riyami, Shah P. Numani, Sharjeel Usmani, Anjali Jain, Syed Furqan Hashmi, Subash Kheruka
article en

Abstract

Meningiomas are the most common primary intracranial tumors, and accurate imaging plays a central role in their diagnosis, risk assessment, treatment planning, and follow-up. Although many meningiomas are slow-growing, their clinical behavior can vary widely, with some tumors showing aggressive growth, postoperative recurrence, or complex extension into the skull base, bone, orbit, or dural venous sinuses. MRI and CT remain the standard imaging modalities for anatomic assessment; however, both have important limitations. MRI may be unable to reliably distinguish a residual or recurrent tumor from postoperative scarring, fibrosis, or radiation-related changes, whereas CT may be limited in differentiating reactive hyperostosis from true osseous tumor infiltration. Molecular imaging with 68Ga-DOTATOC PET/CT has emerged as a valuable complementary technique because of its high affinity for somatostatin receptor subtype 2, which is strongly expressed in most meningiomas. By providing high lesion-to-background contrast, 68Ga-DOTATOC PET/CT may improve lesion conspicuity and provide complementary information about disease extent in selected cases. Available evidence is strongest for problem-solving applications involving equivocal lesions and delineation of skull base, osseous, or optic nerve sheath disease, as well as confirmation of somatostatin receptor expression when receptor-targeted therapy is being considered. Other proposed applications, including tumor grading, prognostication, surgical planning, radiotherapy target refinement, quantitative response assessment, and routine surveillance, remain emerging and require prospective validation. This mini review summarizes the current applications, technical considerations, and limitations of 68Ga-DOTATOC PET/CT in meningioma management.

Journal of Nuclear Medicine Technology
Augusta University (US), Augusta University Health (US), Sultan Qaboos University Hospital (OM), Sultan Qaboos Comprehensive Cancer Care & Research Center (OM), Sultan Qaboos University (OM)
Good health and well-being
Meningioma and schwannoma management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon